Fluvastatin Capsule
Product Images NDC 63629-8737

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluvastatin (NDC 63629-8737). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Fluvastatin (Image 1)

Chemical structure of fluvastatin, illustrating its molecular composition with distinct rings, hydroxyl groups, a fluorine atom, and a sodium ion indicated.*

FDA Label Image

1 (Image 2)

This is a survival curve graph showing the percentage of patients without events over a period of up to 4.5 years since randomization. It compares two groups: one treated with Fluvastatin 80 mg and the other with a placebo. The graph includes statistical values such as Cox P-Value, Log-Rank P-Value, and Hazard Ratio with confidence intervals. Patient numbers at risk and survival percentages are indicated below the x-axis.*

FDA Label Image

1 (Image 3)

A forest plot showing the incidence and risk reduction of various cardiac events comparing Fluvastatin and placebo groups. The horizontal axis represents hazard ratio with confidence intervals, depicting risk reduction percentages and Cox risk ratios for primary and secondary endpoints such as recurrent cardiac events, cardiac death, myocardial infarction, and revascularization procedures.*

FDA Label Image

1 (Image 4)

A bar graph comparing the change in minimum lumen diameter (mm) among patients treated with Fluvastatin versus placebo. The graph is divided into three groups: Monotherapy, All Patients, and Combination Therapy with cholestyramine (CME). Bars show mean changes for each treatment group, with numeric values and p-values indicating statistical comparisons.*

FDA Label Image

1 (Image 5)

A bar chart showing change in percentage diameter stenosis comparing Fluvastatin and placebo in three groups: monotherapy, all patients, and combination therapy with cholestyramine (CME). Bars indicate lower stenosis change for Fluvastatin compared to placebo across groups, with p-values marking statistical significance.*

FDA Label Image

Label (Lbl636298737)

Label for Fluvastatin Capsule, USP 40 mg by Bryant Ranch Prepack. It shows the NDC 63629-8737-1 and indicates the product contains 100 capsules. The label includes storage instructions and a barcode, with the Bryant Ranch Prepack logo in red and blue, and states Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.